Improving clinical practice with an old friend from the neuroimmunology toolkit: acute corticosteroids in LGI1 antibody encephalitis

Improving clinical practice with an old friend from the neuroimmunology toolkit: acute corticosteroids in LGI1 antibody encephalitis

Detalles Bibliográficos
Autor Principal:	Irani, SR
Formato:	Journal article
Idioma:	English
Publicado:	BMJ Publishing Group 2021

Títulos similares

Immunotherapy-responsive chorea as the presenting feature of LGI1-antibody encephalitis.
por: Tofaris, G, et al.
Publicado: (2012)

LGI1 expression and human brain asymmetry: insights from patients with LGI1-antibody encephalitis
por: Jang, Y, et al.
Publicado: (2018)

Faciobrachial dystonic seizures precede Lgi1 antibody limbic encephalitis.
por: Irani, SR, et al.
Publicado: (2011)

LGI1 expression and human brain asymmetry: insights from patients with LGI1-antibody encephalitis
por: Yoonhyuk Jang, et al.
Publicado: (2018-09-01)

Intrathecal B cell activation in LGI1-antibody encephalitis
por: Lehmann-Horn, K, et al.
Publicado: (2020)

Clonal hematopoiesis in LGI1‐antibody encephalitis
por: Soo Jean Shin, et al.
Publicado: (2024-10-01)

Clinical diagnosis of LGI1 antibody encephalitis in an 83-year-old woman
por: Attwood, JE, et al.
Publicado: (2021)

Magnetic resonance imaging characteristics of LGI1-antibody and CASPR2-antibody encephalitis
por: Kelly, MJ, et al.
Publicado: (2024)

Tonic seizures: a diagnostic clue of anti-LGI1 encephalitis?
por: Irani, SR, et al.
Publicado: (2011)

LGI1-antibody encephalitis is characterised by frequent, multifocal clinical and subclinical seizures
por: Aurangzeb, S, et al.
Publicado: (2017)

Antibody Properties Associate with Clinical Phenotype in LGI1 Encephalitis
por: Susann Ludewig, et al.
Publicado: (2023-01-01)

Functional and Structural Brain Alterations in Encephalitis With LGI1 Antibodies
por: Jianping Qiao, et al.
Publicado: (2020-04-01)

Autoimmune Encephalitis: An Expanding Frontier of Neuroimmunology
por: Hong-Zhi Guan, et al.
Publicado: (2016-01-01)

Pathognomonic seizures in limbic encephalitis associated with anti-LGI1 antibodies.
por: Sen, A, et al.
Publicado: (2014)

The immunogenetics of LGI1- and CASPR2-antibody encephalitis: towards aetiology
por: Binks, S
Publicado: (2022)

The distinct pattern of movement disorders in Caspr2 and LGI1 antibody associated autoimmune encephalitis
por: Goevert, F, et al.
Publicado: (2019)

Evaluation of LGI1-antibody Encephalitis, a Rare Cause of Limbic Encephalitis, from Diagnosis to Treatment
por: Halil İbrahim Uslusoy, et al.
Publicado: (2022-06-01)

Psychiatric Manifestation of Anti-LGI1 Encephalitis
por: Dominique Endres, et al.
Publicado: (2020-06-01)

Anti-LGI1 antibody autoimmune encephalitis. Clinical case presentation and literature review
por: A. Stašaitytė, et al.
Publicado: (2021-03-01)

CSF Findings in Chinese Patients with NMDAR, LGI1 and GABABR Antibody-Associated Encephalitis
por: Qiao S, et al.
Publicado: (2024-03-01)

Fire acupuncture for anti-LGI1 antibody autoimmune encephalitis: a case report
por: Yu Liu, et al.
Publicado: (2023-07-01)

A case report of recurrent and MRI negative LGI1 antibody-associated encephalitis
por: Liu Tong, Xia Liping, Jia Yuqin
Publicado: (2023-04-01)

CIELO: a randomized, double-blind, placebo-controlled, phase 3 basket study of satralizumab in patients with NMDAR- or LGI1-antibody encephalitis
por: Gelfand, JM, et al.
Publicado: (2022)

Neuroimmunology in clinical practice /
por: Kalman, Bernadette, et al.
Publicado: (2008)

NMDA receptor antibody related encephalitis
por: Irani, SR
Publicado: (2012)

LGI1 encephalitis: Autoimmune epilepsy or movement disorder
por: Sujit A Jagtap, et al.
Publicado: (2023-01-01)

A Case of LGI1 Encephalitis Presenting with NORSE
por: Gökberk Metin, et al.
Publicado: (2024-03-01)

Pilomotor Seizures in a Patient With LGI1 Encephalitis
por: Jinxia Yang, et al.
Publicado: (2020-02-01)

NMDA receptor antibody encephalitis.
por: Irani, SR, et al.
Publicado: (2011)

A rare case of anti-LGI1 limbic encephalitis with concomitant positive NMDAR antibodies
por: Tuo Ji, et al.
Publicado: (2020-09-01)

Innovation and optimization in autoimmune encephalitis trials: the design and rationale for the Phase 3, randomized study of satralizumab in patients with NMDAR-IgG-antibody-positive or LGI1-IgG-antibody-positive autoimmune encephalitis (CIELO)
por: Lee, S, et al.
Publicado: (2024)

Anti-LGI1 encephalitis with initiating symptom of seizures in children
por: Yang Wang, et al.
Publicado: (2023-04-01)

Comparative effects of domain-specific human monoclonal antibodies against LGI1 on neuronal excitability
por: Sell, J, et al.
Publicado: (2023)

Case report: Seropositive myasthenia gravis complicated by limbic encephalitis positive for antibodies to AMPAR and Lgi1
por: Magne Solberg Nes, et al.
Publicado: (2023-10-01)

Clinical Characteristics of Cognitive Impairment and 1-Year Outcome in Patients With Anti-LGI1 Antibody Encephalitis
por: Hai-lun Hang, et al.
Publicado: (2020-08-01)

Clinical characteristics and short-term prognosis of LGI1 antibody encephalitis: a retrospective case study
por: Weishuai Li, et al.
Publicado: (2018-07-01)

LGI1, CASPR2 and related antibodies: a molecular evolution of the phenotypes
por: Binks, S, et al.
Publicado: (2017)

Innovation and optimization in autoimmune encephalitis trials: the design and rationale for the Phase 3, randomized study of satralizumab in patients with NMDAR-IgG-antibody-positive or LGI1-IgG-antibody-positive autoimmune encephalitis (CIELO)
por: Soon-Tae Lee, et al.
Publicado: (2024-08-01)

Distinct HLA associations of LGI1 and CASPR2-antibody diseases
por: Binks, S, et al.
Publicado: (2018)

EEG-confirmed epileptic activity in a cat with VGKC-complex/LGI1 antibody-associated limbic encephalitis.
por: Pakozdy, A, et al.
Publicado: (2014)